Vitalhub Corp. (TSE:VHI) Given Consensus Recommendation of “Buy” by Analysts

Shares of Vitalhub Corp. (TSE:VHIGet Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is C$13.14.

A number of research firms recently issued reports on VHI. ATB Cormark Capital Markets cut their price target on Vitalhub from C$16.50 to C$15.00 and set an “outperform” rating for the company in a report on Tuesday, March 10th. National Bank Financial decreased their price objective on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a report on Wednesday, May 27th. Finally, Raymond James Financial lowered their price objective on shares of Vitalhub from C$15.00 to C$11.00 and set an “outperform” rating for the company in a research report on Tuesday, March 24th.

Check Out Our Latest Analysis on VHI

Vitalhub Price Performance

VHI stock opened at C$7.05 on Thursday. The business has a fifty day moving average price of C$7.49 and a 200 day moving average price of C$8.01. Vitalhub has a fifty-two week low of C$6.62 and a fifty-two week high of C$14.64. The stock has a market capitalization of C$445.98 million, a price-to-earnings ratio of 58.75, a P/E/G ratio of 1.18 and a beta of 0.88.

Vitalhub (TSE:VHIGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported C$0.04 EPS for the quarter. The company had revenue of C$31.91 million for the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%. On average, equities analysts expect that Vitalhub will post 0.2296467 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Anthony Pius Shen acquired 7,000 shares of the company’s stock in a transaction that occurred on Monday, March 30th. The stock was purchased at an average price of C$7.11 per share, for a total transaction of C$49,770.00. Following the transaction, the director directly owned 12,470 shares of the company’s stock, valued at approximately C$88,661.70. This trade represents a 127.97% increase in their position. Also, Director Steve Garrington sold 10,000 shares of the company’s stock in a transaction on Friday, June 5th. The stock was sold at an average price of C$7.17, for a total value of C$71,700.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately C$358,500. This represents a 16.67% decrease in their position. Company insiders own 18.57% of the company’s stock.

About Vitalhub

(Get Free Report)

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

Featured Stories

Analyst Recommendations for Vitalhub (TSE:VHI)

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.